Enterocolitis, Pseudomembranous
Recent clinical, regulatory, research and industry developments relating to this disease.
European consensus conference on faecal microbiota transplantation in clinical practice.
Fidaxomicin versus vancomycin for Clostridium difficile infection.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes3
- Clostridioides difficile2
- Fecal Microbiota Transplantation1
- Patient Selection1
Leading journals2
- Gut1
- The New England journal of medicine1
Leading researchers8
- Aloi M1
- Arkkila P1
- Cammarota G1
- de Groot P1
- de Vos WM1
- Gasbarrini A1
- Gasbarrini G1
- Golan Y1
Affiliations (unnormalised)6
- "A. Gemelli" Hospital1
- Academic University Medical Center1
- Clinic for Gastroenterology and Hepatology1
- Department of Clinic of Gastroenterology1
- Department of Internal Medicine and Clinical Nutrition1
- Department of Molecular and Clinical Medicine1
Reference
Authoritative identity, definition & identifiers.
An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.